Rose is currently awaiting results from a new round of mice in development
using newer tumor cells.
Not exact matches
Chicago, GenomeWeb — A
new study by researchers from Memorial Sloan Kettering Cancer Center has demonstrated the predictive power of an AR - V7 protein expression test
using Epic Sciences» non-EPCAM-based circulating
tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate cancer.
Unlike conventional chemotherapies and radiation that indiscriminately eradicate fast - growing tissues and ravage people's bodies with side effects,
new therapies specifically target
tumors using tailored cells from individual patients.
«Researchers are
using newer technologies to look directly into
tumors,» she says, «to make sure immunotherapies induce a response that works in the
tumor.»
They discovered that the chemicals and radiation
used to kill
tumor cells damage the stem cell reservoir in the hippocampus and nearly halt the formation of
new neurons in both children and adults.
In a paper published in the May 5 online issue of The Oncologist, researchers at the University of California, San Diego School of Medicine and Moores Cancer Center detail their experience evaluating 34 patients between December 2012 and June 2013
using a molecular
tumor board — a
new type of advisory group comprised of multidisciplinary experts, including those in the fields of
tumor genetics, basic science and bioinformatics.
For some years now, a
new class of drugs called antibody - drug conjugates (ADCs) have been
used, which work in two ways: they consist of an antibody that binds selectively to the
tumor cell receptor and interrupts the signal to propagate; they also act as a transport vehicle for a chemical substance that enters the cancer cells with the antibody and triggers their death.
Another possible application for the
new machine is generating peptides that could be
used as personalized cancer vaccines targeting unique proteins found in individual patients»
tumors.
In this
new study published in Nature, Alexandra Van Keymeulen and colleagues
used state of the art genetic mouse models to identify the cellular origin of PIK3CA and p53 induced breast
tumors.
That's because hospitals are equipped with powerful
new scanning machines primarily
used to identify
tumors, ballooning blood vessels, bone fractures, and a wide range of disorders in people.
Finding
new treatments is critical because less than 5 percent of patients with pancreatic neuroendocrine
tumors respond to everolimus, the most commonly
used pharmaceutical, François said.
Interphone compared surveyed cell phone
use in 6,420 people with brain
tumors to that of 7,658 healthy people in 13 developed countries — Australia, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan,
New Zealand, Norway, Sweden and the U.K. — to try to determine whether people with brain
tumors had
used their cell phones more than healthy people, an association that might suggest that cell phones caused the
tumors.
The initial experiments made
use of cancer cells that Quiñones - Hinojosa and his team removed from willing patients and grew in the laboratory until they formed little spheres of cells, termed oncospheres, likely to be the most resistant to chemotherapy and radiation, and capable of creating
new tumors.
Scientists at Barrow Neurological Institute have recently made discoveries about
use of a
new technology for imaging brain
tumors in the operating room — a finding that could have important implications for identifying and locating invading cells at the edge of a brain
tumor.
His research largely focuses on
new means to incorporate imaging methods to view cells of brain
tumors with a hand held instrument that a neurosurgeon can
use to visualize the individual cells during the progress of the operation.
The
new test
uses a highly sensitive gene mutation detection method that is based on the partitioning of DNA into droplets to detect specific circulating
tumor DNA mutations and RNA variants in whole blood.
To overcome these problems, Min and his team developed a
new modality to visualize glucose uptake activity inside single cells based on stimulated Raman scattering (SRS) imaging, and demonstrated its
use in live cancer cells,
tumor xenograft tissues, primary neurons and mouse brain tissues.
In the
new studies, three independent groups
used genetic cell - marking techniques to trace the proliferation of certain cells within growing
tumors.
In the past few years, Vogelstein and Kinzler have shifted away from discovering
new cancer genes to a less glamorous pursuit:
using genetic tests to detect common
tumors as early as possible, when they are easiest to cure.
In the first test
using KnIT, the team sought to identify
new protein kinases that phosphorylate (or turn on) the protein
tumor suppressor p53.
In a
new International Journal of Cancer analysis, researchers found a link between maternal residential pesticide
use — particularly insecticides — and the risk of childhood brain
tumors.
Researchers at The Rockefeller University have shown that a
new technique
using RNA interference is able to find genes that cause epidermal
tumor growth in months rather than the decades it may take
using traditional methods employing specially bred, genetically altered mice.
«
New technology can detect tiny ovarian
tumors: «Synthetic biomarkers» could be
used to diagnose ovarian cancer months earlier than now possible.»
In the
new study, the researchers
used a combination of four different therapies to activate both of the immune system's two branches, producing a coordinated attack that led to the complete disappearance of large, aggressive
tumors in mice.
CellSearch is
used primarily to check the progress of cancer treatment, whereas U.C.L.A.'s imaging technology could find cancerous cells at an earlier stage, before they can form a
new tumor.
To find
tumors via MRI, the Stanford team
used a
new contrast agent consisting of nanoparticles of iron.
In the
new paper, the researchers
used CRISPR to introduce cancer - causing mutations into the organoids and then delivered them via colonoscopy to the colon, where they attached to the lining and formed
tumors.
It also may have helped several others by boosting the power of a
new type of cancer drug that
uses a different mechanism to unleash an immune attack on the
tumor.
Using their
new model, the researchers found that certain parameters about the way a
tumor grows could successfully and accurately predict its response to anti-angiogenic treatment that targets VEGF activity.
In several steps
using a
new strategy and a novel drug, Burkhard Becher's team from the Institute of Experimental Immunology at the University of Zurich has now succeeded in doing exactly this in the case of glioblastoma, one of the most dangerous brain
tumors.
A
new study led by scientists at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) suggests that dopamine — an inexpensive drug currently
used to treat heart, vascular and kidney disorders — can be safely
used in cancer treatment to curb the growth of blood vessels in
tumors.
«Age - old malaria treatment found to improve nanoparticle delivery to
tumors: Nanomedicine researchers find
new use for 70 - year - old drug.»
July 21, 2006 Novel technique
used to remove
tumor in infant's liver On June 28, infant Chloe Lobins received a liver resection — removal of part of the organ — and a
new chance at life at the University of Chicago Comer Children's Hospital.
The safe
use of a stem - cell - based therapy against brain metastasis would require preventing the engineered cells from persisting within the brain, where they could affect normal tissue and possibly give rise to
new tumors.
At a time when gene therapy has been revived as a potent form of cancer treatment, a
new approach would
use nanoparticles, rather than viruses, to deliver strands of DNA or RNA to
tumors.
In a 1988 paper summarizing his findings, Fiebig concluded that xenograft mice were wonderful models for broadly testing
new drugs against human
tumors, but they «can not be
used as a clinical routine method» for predicting patient treatment.1 The idea of
using xenograft mice as personal avatars for cancer patients was discarded.
Now, patients with pancreatic cancer desperate for
new treatment options will potentially benefit from a powerful
new technology that
uses genetic engineering to turn their own immune cells into «specially trained assassins» capable of finding, attacking, and eliminating pancreatic cancer
tumors.
School of Allied Health Sciences» Steen Madsen is exploring
new treatment methods for primary brain
tumors —
tumors that originate in the brain —
using nanoparticles and lasers.
We need a
new type of vaccine that
uses select components of a microbe or
tumor cell or other cause of disease, and administers these with other defined substances, such as adjuvants, that directly exploit immunology.»
Magnus Essand and Justyna Leja at SciLifeLab / Uppsala University has together with their colleagues developed a
new treatment for
tumors,
using viruses.
Using new technologies to analyze thousands of genes and proteins simultaneously from
tumors, Dr. Chak hopes to identify molecular patterns that will predict an individual's response to specific agents.
$ 1.8 M Supports Cancer Drug Discovery on Commonly Mutated Gene
New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed
Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem Cell Transplant Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways in the Development of Ovarian Cancer GMNews.com - March 2, 2016 Differences in Type of Small Protein may further Elucidate Lung Cancer Risk in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed
Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette
Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney
Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the Lung Cancer Ribbon?
Now, in a
new study in the journal Cancer Cell, Shaw and a team of scientists at the Salk Institute for Biological Studies found that phenformin, a derivative of the widely -
used diabetes drug metformin, decreased the size of lung
tumors in mice and increased the animals» survival.
New and innovative technology would
use radiation beams to target
tumors and leave healthy tissue intact.
CXCR4 is a receptor that cancer cells
use like antennae to feel their way from their parent
tumor to distinct sites in the body where they will establish a
new tumor.
Since starting her
new role as an investigator in the In Vivo Pharmacology group at Novartis Oncology, Bhang has been working on
using the ClonTracer library to monitor clonal dynamics following drug treatment in cell line and primary
tumor xenograft models.
Motion model ultrasound localization microscopy (mULM) is a
new tool
using CEUS to morphologically and functionally characterize fine vascular networks in
tumors at super-resolution.
Other research is investigating whether agonist reagents that can signal various immune cells such as T cells, dendritic cells, or NK cells, through the TNF family receptors OX40, 4 - 1BB, HVEM, or LTβR can be
used to increase natural immune responses to viruses or
tumors that might lead to
new strategies for vaccination.
Bryan Choi, the recipient of a Student Training and Research in
Tumor Immunology (STaRT) grant at Duke University, is working to develop a
new strategy
using Bispecific T cell Engagers (BiTEs) to treat glioblastoma.
In addition,
new small molecule drugs are being
used that target important survival pathways in NHL
tumor cells.